{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:14:34Z","timestamp":1784128474563,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00520-023-08152-0","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T06:02:20Z","timestamp":1699596140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers"],"prefix":"10.1007","volume":"31","author":[{"given":"Jessica Fernandes","family":"Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Domingues","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina Nunez","family":"Seiwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Sim\u00e3o","family":"Gandolpho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius Campos","family":"Molla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Guaran\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone A.","family":"Nou\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4867-0014","authenticated-orcid":false,"given":"Marcio","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso Arrais","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"8152_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijantimicag.2007.06.012","volume":"30","author":"J Klastersky","year":"2007","unstructured":"Klastersky J, Ameye L, Maertens J et al (2007) Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30:51\u201359. https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.06.012","journal-title":"Int J Antimicrob Agents"},{"key":"8152_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1086\/374339","volume":"36","author":"H Wisplinghoff","year":"2003","unstructured":"Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB (2003) Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 36:1103\u20131110. https:\/\/doi.org\/10.1086\/374339","journal-title":"Clin Infect Dis"},{"issue":"6","key":"8152_CR3","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/cid\/ciz319","volume":"70","author":"G Martinez-Nadal","year":"2020","unstructured":"Martinez-Nadal G, Puerta-Alcalde P, Gudiol C et al (2020) Inappropriate empirical antibiotic treatment in high-risk neutropenic patients with bacteremia in the era of multidrug resistance. Clin Infect Dis 70(6):1068\u20131074. https:\/\/doi.org\/10.1093\/cid\/ciz319","journal-title":"Clin Infect Dis"},{"key":"8152_CR4","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1128\/aac.02561-14","volume":"58","author":"RG Rosa","year":"2014","unstructured":"Rosa RG, Goldani LZ (2014) Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia. Antimicrob Agents Chemother 58:3799\u20133803. https:\/\/doi.org\/10.1128\/aac.02561-14","journal-title":"Antimicrob Agents Chemother"},{"key":"8152_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.diagmicrobio.2017.05.003","volume":"88","author":"P Tofas","year":"2017","unstructured":"Tofas P, Samarkos M, Piperaki ET et al (2017) Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: Risk factors, treatment, and outcome. Diagn Microbiol Infect Dis 88:335\u2013341. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.05.003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"8152_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1128\/aac.00901-06","volume":"51","author":"RB Osih","year":"2007","unstructured":"Osih RB, McGregor JC, Rich SE et al (2007) Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 51:839\u2013844. https:\/\/doi.org\/10.1128\/aac.00901-06","journal-title":"Antimicrob Agents Chemother"},{"key":"8152_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1371\/journal.pone.0199531","volume":"13","author":"C Garcia-Vidal","year":"2018","unstructured":"Garcia-Vidal C, Cardozo-Espinola C, Puerta-Alcalde P et al (2018) Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance. PLoS ONE 13:e1-12. https:\/\/doi.org\/10.1371\/journal.pone.0199531","journal-title":"PLoS ONE"},{"issue":"12","key":"8152_CR8","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","volume":"98","author":"D Averbuch","year":"2013","unstructured":"Averbuch D, Orasch C, Cordonnier C et al (2013) European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: Summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 98(12):1826\u20131835. https:\/\/doi.org\/10.3324\/haematol.2013.091025","journal-title":"Haematologica"},{"issue":"4","key":"8152_CR9","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56\u2013e93. https:\/\/doi.org\/10.1093\/cid\/cir073","journal-title":"Clin Infect Dis"},{"key":"8152_CR10","unstructured":"Baden LR, Swaminathan S, Almyroudis NG et al. (2020). National Comprehensive Cancer Network. Prevention and Treatment of Cancer-Related Infections. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/infections.pdf. Accessed June 30, 2023"},{"key":"8152_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","volume":"32","author":"E Montassier","year":"2013","unstructured":"Montassier E, Batard E, Gastinne T, Potel G, de La Cocheti\u00e8re MF (2013) Recent changes in bacteremia in patients with cancer: A systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis 32:841\u2013850. https:\/\/doi.org\/10.1007\/s10096-013-1819-7","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"8152_CR12","doi-asserted-by":"publisher","first-page":"e0174421","DOI":"10.1128\/AAC.01744-21","volume":"66","author":"M Chumbita","year":"2022","unstructured":"Chumbita M, Puerta-Alcalde P, Gudiol C et al (2022) Impact of empirical antibiotic regimens on mortality in neutropenic patients with bloodstream infection presenting with septic shock. Antimicrob Agents Chemother 66(2):e0174421. https:\/\/doi.org\/10.1128\/AAC.01744-21","journal-title":"Antimicrob Agents Chemother"},{"key":"8152_CR13","doi-asserted-by":"publisher","first-page":"e01250","DOI":"10.1128\/aac.01250-19","volume":"63","author":"M Guarana","year":"2019","unstructured":"Guarana M, Nucci M, Nouer SA (2019) Shock and early death in hematologic patients with febrile neutropenia. Antimicrob Agents Chemother 63:e01250-e1319. https:\/\/doi.org\/10.1128\/aac.01250-19","journal-title":"Antimicrob Agents Chemother"},{"key":"8152_CR14","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1128\/aac.36.5.1062","volume":"36","author":"R Ramphal","year":"1992","unstructured":"Ramphal R, Bolger M, Oblon DJ et al (1992) Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: A randomized prospective study. Antimicrob Agents Chemother 36:1062\u20131067. https:\/\/doi.org\/10.1128\/aac.36.5.1062","journal-title":"Antimicrob Agents Chemother"},{"key":"8152_CR15","doi-asserted-by":"publisher","first-page":"CD003914","DOI":"10.1002\/14651858.CD003914.pub4","volume":"6","author":"O Beyar-Katz","year":"2017","unstructured":"Beyar-Katz O, Dickstein Y, Borok S, Vidal L, Leibovici L, Paul M (2017) Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer. Cochrane Database Syst Rev 6:CD003914. https:\/\/doi.org\/10.1002\/14651858.CD003914.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"8152_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1086\/376637","volume":"37","author":"A Cometta","year":"2003","unstructured":"Cometta A, Kern WV, De Bock R et al (2003) Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. Clin Infect Dis 37:382\u2013389. https:\/\/doi.org\/10.1086\/376637","journal-title":"Clin Infect Dis"},{"issue":"6","key":"8152_CR17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/jac\/45.6.843","volume":"45","author":"Z Erjavec","year":"2000","unstructured":"Erjavec Z, de Vries-Hospers HG, Laseur M, Halie RM, Daenen S (2000) A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy. J Antimicrob Chemother 45(6):843\u2013849. https:\/\/doi.org\/10.1093\/jac\/45.6.843","journal-title":"J Antimicrob Chemother"},{"key":"8152_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/1078155216668672","volume":"23","author":"M Vicente","year":"2017","unstructured":"Vicente M, Al-Nahedh M, Parsad S et al (2017) Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia. J Oncol Pharm Pract 23:575\u2013581. https:\/\/doi.org\/10.1177\/1078155216668672","journal-title":"J Oncol Pharm Pract"},{"key":"8152_CR19","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/s41409-020-0811-y","volume":"55","author":"A Verlinden","year":"2020","unstructured":"Verlinden A, Mikulska M, Knelange NS et al (2020) Current antimicrobial practice in febrile neutropenia across Europe and Asia: The EBMT Infectious Disease Working Party survey. Bone Marrow Transplant 55:1588\u20131594. https:\/\/doi.org\/10.1038\/s41409-020-0811-y","journal-title":"Bone Marrow Transplant"},{"key":"8152_CR20","unstructured":"National Healthcare safety Network (2023). Patient Safety Component Manual. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/pcsmanual_current.pdf. Accessed June 30, 2023"},{"issue":"1","key":"8152_CR21","doi-asserted-by":"publisher","first-page":"ofu006","DOI":"10.1093\/ofid\/ofu006","volume":"1","author":"J Libuit","year":"2014","unstructured":"Libuit J, Whitman A, Wolfe R, Washington CS (2014) Empiric vancomycin use in febrile neutropenic oncology patients. Open Forum Infectious Diseases, 10 1(1):ofu006. https:\/\/doi.org\/10.1093\/ofid\/ofu006","journal-title":"Open Forum Infectious Diseases, 10"},{"key":"8152_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijid.2018.02.016","volume":"69","author":"DB Chastain","year":"2018","unstructured":"Chastain DB, Wheeler S, Franco-Paredes C et al (2018) Evaluating guideline adherence regarding empirical vancomycin use in patients with neutropenic fever. Int J Infect Dis 69:88\u201393. https:\/\/doi.org\/10.1016\/j.ijid.2018.02.016","journal-title":"Int J Infect Dis"},{"issue":"2","key":"8152_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3201\/eid0702.010237","volume":"7","author":"FC Tenover","year":"2001","unstructured":"Tenover FC, Biddle JW, Lancaster MV (2001) Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 7(2):327\u2013332","journal-title":"Emerg Infect Dis"},{"key":"8152_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3201\/eid0702.010237","volume":"55","author":"RG Finch","year":"2005","unstructured":"Finch RG, Eliopoulos GM (2005) Safety and efficacy of glycopeptide antibiotics. J Antimicrob Chemother 55:5\u201313. https:\/\/doi.org\/10.3201\/eid0702.010237","journal-title":"J Antimicrob Chemother"},{"key":"8152_CR25","first-page":"694","volume":"19","author":"FR Bruniera","year":"2015","unstructured":"Bruniera FR, Ferreira FM, Saviolli LR et al (2015) The use of vancomycin with its therapeutic and adverse effects: A review. Eur Rev Med Pharmacol Sci 19:694\u2013700","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"8152_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s13318-017-0456-4","volume":"43","author":"F Elbarbry","year":"2018","unstructured":"Elbarbry F (2018) Vancomycin dosing and monitoring: Critical evaluation of the current practice. Eur J Drug Metab Pharmacokinet 43:259\u2013268. https:\/\/doi.org\/10.1007\/s13318-017-0456-4","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"8152_CR27","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1182\/bloodadvances.2020001984","volume":"4","author":"S Zhang","year":"2020","unstructured":"Zhang S, Shanley R, Weisdorf DJ, Rashidi A (2020) Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation. Blood Adv 4:2640\u20132643. https:\/\/doi.org\/10.1182\/bloodadvances.2020001984","journal-title":"Blood Adv"},{"issue":"9","key":"8152_CR28","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1900623","volume":"382","author":"JU Peled","year":"2020","unstructured":"Peled JU, Gomes ALC, Devlin SM et al (2020) Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N Engl J Med 382(9):822\u2013834. https:\/\/doi.org\/10.1056\/NEJMoa1900623","journal-title":"N Engl J Med"},{"issue":"1","key":"8152_CR29","doi-asserted-by":"publisher","first-page":"2178805","DOI":"10.1080\/19490976.2023.2178805","volume":"15","author":"YF van Lier","year":"2023","unstructured":"van Lier YF, Vos J, Blom B, Hazenberg MD (2023) Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease. Gut Microbes 15(1):2178805. https:\/\/doi.org\/10.1080\/19490976.2023.2178805","journal-title":"Gut Microbes"},{"issue":"5","key":"8152_CR30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.bbmt.2017.02.006","volume":"23","author":"D Weber","year":"2017","unstructured":"Weber D, Jenq RR, Peled JU et al (2017) Microbiota disruption induced by early use of broad-spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 23(5):845\u2013852. https:\/\/doi.org\/10.1016\/j.bbmt.2017.02.006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"8152_CR31","doi-asserted-by":"publisher","first-page":"e2317188","DOI":"10.1001\/jamanetworkopen.2023.17188","volume":"6","author":"A Rashidi","year":"2023","unstructured":"Rashidi A, Gao F, Fredricks DN et al (2023) Analysis of antibiotic exposure and development of acute graft-vs-host disease following allogeneic hematopoietic cell transplantation. JAMA Netw Open 6(6):e2317188. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.17188","journal-title":"JAMA Netw Open"},{"issue":"5","key":"8152_CR32","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/cid\/ciy711","volume":"68","author":"D Weber","year":"2019","unstructured":"Weber D, Hiergeist A, Weber M, Dettmer K, Wolff D, Hahn J, Herr W, Gessner A, Holler E (2019) Detrimental effect of broad-spectrum antibiotics on intestinal microbiome diversity in patients after allogeneic stem cell transplantation: Lack of commensal sparing antibiotics. Clin Infect Dis 68(5):830\u2013839. https:\/\/doi.org\/10.1093\/cid\/ciy711","journal-title":"Clin Infect Dis"},{"key":"8152_CR33","doi-asserted-by":"publisher","first-page":"848580","DOI":"10.3389\/fcimb.2022.848580","volume":"12","author":"S Franklin","year":"2022","unstructured":"Franklin S, Aitken SL, Shi Y, Sahasrabhojane PV, Robinson S, Peterson CB, Daver N, Ajami NA, Kontoyiannis DP, Shelburne SA, Galloway-Pe\u00f1a J (2022) Oral and stool microbiome coalescence and its association with antibiotic exposure in acute leukemia patients. Front Cell Infect Microbiol 12:848580. https:\/\/doi.org\/10.3389\/fcimb.2022.848580","journal-title":"Front Cell Infect Microbiol"},{"key":"8152_CR34","unstructured":"World Health Organization (2021). Antimicrobial resistance. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance. Accessed June 30, 2023"},{"issue":"19","key":"8152_CR35","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1056\/NEJM197105132841904","volume":"284","author":"S Schimpff","year":"1971","unstructured":"Schimpff S, Satterlee W, Young VM, Serpick A (1971) Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 284(19):1061\u20131065. https:\/\/doi.org\/10.1056\/NEJM197105132841904","journal-title":"N Engl J Med"},{"issue":"1","key":"8152_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1445-5994.2010.02340.x","volume":"41","author":"CS Tam","year":"2011","unstructured":"Tam CS, O\u2019Reilly M, Andresen D, Lingaratnam S, Kelly A, Burbury K, Turnidge J, Slavin MA, Worth LJ, Dawson L, Thursky KA, Australian Consensus Guidelines Steering Committee (2011) Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee. Internal Medicine Journal 41(1):90\u2013101. https:\/\/doi.org\/10.1111\/j.1445-5994.2010.02340.x","journal-title":"Internal Medicine Journal"},{"issue":"4","key":"8152_CR37","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1378\/chest.130.4.947","volume":"130","author":"MN Jeffres","year":"2006","unstructured":"Jeffres MN, Isakow W, Doherty JA, McKinnon PS, Ritchie DJ, Micek ST, Kollef MH (2006) Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest 130(4):947\u2013955. https:\/\/doi.org\/10.1378\/chest.130.4.947","journal-title":"Chest"},{"issue":"2","key":"8152_CR38","doi-asserted-by":"publisher","first-page":"050","DOI":"10.1093\/ofid\/ofx050","volume":"4","author":"MG Schuster","year":"2017","unstructured":"Schuster MG, Cleveland AA, Dubberke ER, Kauffman CA, Avery RK, Husain S, Paterson DL, Silveira FP, Chiller TM, Benedict K, Murphy K, Pappas PG (2017) Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective Cohort Study. Open Forum Infect Dis 22 4(2):050. https:\/\/doi.org\/10.1093\/ofid\/ofx050","journal-title":"Open Forum Infect Dis 22"},{"issue":"6","key":"8152_CR39","doi-asserted-by":"publisher","first-page":"E629","DOI":"10.1111\/j.1399-0012.2011.01495.x","volume":"25","author":"M Aguilar-Guisado","year":"2011","unstructured":"Aguilar-Guisado M, Jim\u00e9nez-Jambrina M, Espigado I, Rovira M, Martino R, Oriol A, Borrell N, Ruiz I, Mart\u00edn-D\u00e1vila P, de la C\u00e1mara R, Salavert M, de la Torre J, Cisneros JM (2011) Spanish Network for Research in Infectious Diseases. Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study. Clin Transplant 25(6):E629-38. https:\/\/doi.org\/10.1111\/j.1399-0012.2011.01495.x","journal-title":"Clin Transplant"},{"issue":"4","key":"8152_CR40","doi-asserted-by":"publisher","first-page":"e13612","DOI":"10.1111\/tid.13612","volume":"23","author":"M Talagtag","year":"2021","unstructured":"Talagtag M, Patel TS, Scappaticci GB, Perissinotti AJ, Schepers AJ, Petty LA, Pettit KM, Burke PW, Bixby DL, Marini BL (2021) Utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening in patients with acute myeloid leukemia (AML). Transpl Infect Dis 23(4):e13612. https:\/\/doi.org\/10.1111\/tid.13612","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"8152_CR41","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/cncr.21847","volume":"106","author":"NM Kuderer","year":"2006","unstructured":"Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106(10):2258\u20132266. https:\/\/doi.org\/10.1002\/cncr.21847","journal-title":"Cancer"},{"issue":"23","key":"8152_CR42","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1002\/cncr.25332","volume":"116","author":"GH Lyman","year":"2010","unstructured":"Lyman GH, Michels SL, Reynolds MW, Barron R, Tomic KS, Yu J (2010) Risk of mortality in patients with cancer who experience febrile neutropenia. Cancer 116(23):5555\u20135563. https:\/\/doi.org\/10.1002\/cncr.25332","journal-title":"Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08152-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-08152-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08152-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T14:08:25Z","timestamp":1703167705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-08152-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["8152"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-08152-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]},"assertion":[{"value":"9 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an observational study. The Ethics Committee of Hospital Universit\u00e1rio Clementino Fraga Filho approved the study, and a waiver of informed consent was granted by the Ethics Committee. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"A waiver of informed consent was granted by the Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"687"}}